Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical antibiotic cocktail for prevention of infection after bilateral total hip arthroplasty
IRCT20250518065782N1Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- May 2025
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cefazolin, clindamycin, gentamicin and vancomycin in surgical site infection (SSI) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Occurrence of postoperative infection and Type of postoperative infection. Started May 2025; status: completed.
02
Drugs
cefazolinclindamycingentamicinvancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20250518065782N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250518065782N1.